Au­rinia re­struc­tures board, bring­ing in Kevin Tang and keep­ing CEO

Au­rinia Phar­ma­ceu­ti­cals of­fered an olive branch to a group of share­hold­ers clam­or­ing for change. It’s shrink­ing its board by two seats, and it added ac­tivist …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER